All In Biotech

Drug Trial Radar · NCT00314184

Quetiapine Fumarate Bipolar Maintenance Monotherapy

Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Quetiapine Fumarate and Lithium as Monotherapy for up to 104 Weeks Maintenance Treatment of Bipolar I Disorder in Adult Patients

Last checked: Nov 19, 2026Latest source record: Dec 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,255 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,255

Actual

Start

Mar 2005

Primary completion

Not stated

Study completion Jul 2007

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Apr 13, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, parallel-group, double-blind, placebo-controlled study to evaluate the efficacy and safety of quetiapine and lithium (comparator in the study) for up to 104 weeks of maintenance treatment in adult patients with Bipolar I Disorder. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Conditions

  • Bipolar Disorder

Interventions

  • quetiapine fumarateDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time from randomization to recurrence of a mood event

Locations

95 sites in 15 countries. Site status is shown where the registry gives one.

  • Research Site

    Cerritos, California

  • Research Site

    San Diego, California

  • Research Site

    Santa Ana, California

  • Research Site

    Washington D.C., District of Columbia

  • Research Site

    Gainesville, Florida

  • Research Site

    Jacksonville, Florida

  • Research Site

    North Miami, Florida

  • Research Site

    Orlando, Florida

  • Research Site

    Atlanta, Georgia

  • Research Site

    Eagle, Idaho

  • Research Site

    Hoffman Estates, Illinois

  • Research Site

    Terre Haute, Indiana

  • Research Site

    Shreveport, Louisiana

  • Research Site

    Flowood, Mississippi

  • Research Site

    Saint Charles, Missouri

  • Research Site

    Las Vegas, Nevada

  • Research Site

    Clementon, New Jersey

  • Research Site

    Rochester, New York

  • Research Site

    Raleigh, North Carolina

  • Research Site

    Fargo, North Dakota

  • Research Site

    Portland, Oregon

  • Research Site

    Salem, Oregon

  • Research Site

    Philadelphia, Pennsylvania

  • Research Site

    Memphis, Tennessee

  • Research Site

    Austin, Texas

  • Research Site

    Lake Jackson, Texas

  • Research Site

    Richmond, Virginia

  • Research Site

    Bellevue, Washington

  • Research Site

    Kirkland, Washington

  • Research Site

    Seattle, Washington

  • Research Site

    Capital Federal, Argentina

  • Research Site

    Córdoba, Argentina

  • Research Site

    La Plata, Argentina

  • Research Site

    Lanus, Argentina

  • Research Site

    Mendoza, Argentina

  • Research Site

    Rosario, Argentina

  • Research Site

    Burgas, Bulgaria

  • Research Site

    Plovdiv, Bulgaria

  • Research Site

    Sofia, Bulgaria

  • Research Site

    Antioquia, Colombia

Showing 40 of 95 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.